The differences of Matrix Metalloproteinases (MMP-9 and MMP-13) in chronic inflammatory rheumatic diseases

ESER B., TECER D., SEPİCİ DİNÇEL A.

ROMANIAN JOURNAL OF MILITARY MEDICINE, vol.125, no.2, pp.325-329, 2022 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 125 Issue: 2
  • Publication Date: 2022
  • Doi Number: 10.55453/rjmm.2022.125.2.23
  • Journal Name: ROMANIAN JOURNAL OF MILITARY MEDICINE
  • Journal Indexes: Emerging Sources Citation Index (ESCI)
  • Page Numbers: pp.325-329
  • Keywords: matrix metalloproteinases, primary Sjogren's syndrome (pSS), psoriatic arthritis (PsA), rheumatoid arthritis (RA), PRIMARY SJOGRENS-SYNDROME, CLASSIFICATION CRITERIA, MATRIX-METALLOPROTEINASE-9 MMP-9, PSORIATIC-ARTHRITIS, AMERICAN-COLLEGE, SALIVARY-GLANDS, EXPRESSION, INHIBITOR
  • Gazi University Affiliated: Yes

Abstract

Objectives: Primary Sjogren's Syndrome (pSS), Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA) are systemic, autoimmune, and chronic inflammatory rheumatic diseases that collagenases and gelatinases are effective and valuable in the pathophysiology of these diseases. The aim of this study is to compare the levels of MMP-9 (gelatinase-B) and MMP-13 (collagenase-3) in pSS to PsA, RA and healthy controls.